CAPRICOR THERAPEUTICS, INC. (CAPR) › Operating IncomeCAPRICOR THERAPEUTICS, INC. (CAPR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$6.29M2011: -$4.90M2012: -$2.10M2013: -$6.90M2014: -$6.02M2015: -$12.61M2016: -$16.98M2017: -$12.86M2018: -$15.33M2019: -$7.73M2020: -$13.69M2021: -$20.94M2022: -$29.70M2023: -$24.08M2024: -$42.56M2025: -$108.14M-$108.14M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$108.14M-154.1%2024-$42.56M-76.8%2023-$24.08M+18.9%2022-$29.70M-41.8%2021-$20.94M-52.9%2020-$13.69M-77.0%2019-$7.73M+49.5%2018-$15.33M-19.2%2017-$12.86M+24.2%2016-$16.98M-34.6%2015-$12.61M-109.6%2014-$6.02M+12.8%2013-$6.90M-228.7%2012-$2.10M+57.1%2011-$4.90M+22.2%2010-$6.29M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share